PharmaLedger has had a busy year. After morphing from a pharmaceutical consortium into a non-profit association, the group launched its first product, electronic Product Information (ePI). Those product pamphlets inside a box of medicine will soon be a thing of the past. Instead, patients scan the barcode on the box of drugs with their mobile phones. In addition to the ePI launch, the association has attracted 11 new members.
Around the start of the pandemic, PharmaLedger launched as a 29 member consortium to explore blockchain for healthcare innovation. Originally it was an EU-funded initiative with a dozen major pharmaceutical companies. Last year the group decided to continue the work as a Swiss-based non-profit association with paying members.
The new members still feature many from Europe, but overall there’s a more global representation including Japan’s Takeda Pharmaceuticals and Asian distributor and healthcare provider Zuellig Pharma.
Article continues …
Want the full story? Pro subscribers get complete articles, exclusive industry analysis, and early access to legislative updates that keep you ahead of the competition. Join the professionals who are choosing deeper insights over surface level news.
